Skye Bioscience Inc.

SKYE | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.75

-$0.03 (-1.69%)

Sep 22, 2026, 12:53 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	5.88M	68.42M	1.26M	1.24M	8.98M	2.47M
Short-Term Investments	19.85M	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	53.91K	53.91K	8.31K	8.31K	8.31K	n/a
Receivables	10.47K	5.07K	158.24K	74.12K	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	13.78K	207.21K	9.64M	6.74M	61.44K	4.84K
Total Current Assets	27.09M	70.83M	11.65M	8.94M	9.61M	2.66M
Property-Plant & Equipment	1.17M	1.88M	281.26K	159.05K	234.68K	7.34K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.22M	1.94M	289.57K	167.35K	242.99K	7.34K
Total Assets	28.31M	72.76M	11.94M	9.11M	9.86M	2.67M
Account Payables	2.03M	569.25K	956.75K	1.79M	900.01K	381.37K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	4.37M	1.9M	1.97M	64.06K
Other Current Liabilities	2.63M	549.15K	969.62K	7.48M	435.57K	38.57K
Total Current Liabilities	8.21M	4.34M	13.9M	12.12M	3.91M	787.2K
Long-Term Debt	84K	n/a	n/a	n/a	n/a	1.43M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	84K	273.16K	171.23K	n/a	78.7K	1.43M
Total Liabilities	8.29M	4.61M	14.07M	12.12M	3.99M	2.22M
Total Debt	273.65K	455.59K	4.62M	1.98M	2.14M	1.5M
Book Value	20.02M	68.15M	-2.13M	-3.01M	5.86M	450.79K
Book Value Per Share	4.04	14.94	-2.43	-10.83	28.84	3.90
Common Stock	33.38K	30.98K	12.35K	3.65K	476.11K	288.07K
Retained Earnings	-186.87M	-130.95M	-104.38M	-66.74M	-47.26M	-38.73M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	20.02M	68.15M	-2.13M	-3.01M	5.86M	450.79K
Total Investments	19.85M	n/a	n/a	n/a	n/a	n/a